Trivarx logo
TRI
Health Care Equipment & Services

Trivarx

Short interest
0.01%
0.00 pp 30d
as of 24 Mar 2026
Reported shorts
150.5K
Shares on issue
1.154B

Trivarx (TRI) financials

Results, ratios and statements

Latest result

Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency

Revenue
$14.6K (source: ASX (Markit))vs $1.1M (source: ASX (Markit)) (FY25)
ASX (Markit), as at 14 Oct 2026
NPAT
−$8.8M (source: ASX (Markit))vs −$943.2K (source: ASX (Markit)) (FY25)
ASX (Markit), as at 14 Oct 2026
EPS (diluted)
−$0.96 (source: Derived: trailing 12 months at year end)vs n/a (FY25)
Derived: trailing 12 months at year end, as at 14 Oct 2026
Rev YoY
n/mFY
EPS YoY
n/aFY
  • ASX (Markit)
  • Derived: trailing 12 months at year end

Summary of 2026 Annual Report, 29 Sep 2026

TrivarX reported a statutory net loss of $8.8 million for the financial year ended 30 June 2026. No dividend was declared. The company raised $4.2 million via a placement and acquired the Stabl-Im imaging platform, which it is prioritising alongside maintaining its mental health IP for possible licensing.

Automated summary of the filing; the filing itself is the record.

Key ratios

Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 14 Oct 2026

Gross margin
n/a
Operating margin
−57,805.6%
Net margin
−60,141.7%
FCF margin
−18,356.3%
ROE
n/a
ROA
n/a
FCF conversion
n/a
Net debt (excl. leases)
n/a
Net debt / EBITDA
n/a
Current ratio
n/a
Interest cover
−674.4×
Cash dividends paid / net profit
n/a
Market cap
n/a (listed unit is not one ordinary share)
P/E
n/a (listed unit is not one ordinary share)
P/B
n/a (listed unit is not one ordinary share)

Ratios use the reporting currency (AUD); market cap is in AUD. Sources: ASX (Markit) and Derived: trailing 12 months at year end, as at 14 Oct 2026.

Financial statements

Figures in AUD, the reporting currency; Yahoo Finance unless marked

TRI income, newest period first, figures in AUD
Line itemFY26FY25FY24FY23
Revenue$14.6K (source: ASX (Markit))$1.1M (source: ASX (Markit))$893.3K (source: ASX (Markit))$22.1K
Gross profitn/an/an/a$21.9K
Operating income−$8.4M (source: Derived: trailing 12 months at year end)n/a−$2.3M−$2.7M
EBITDA−$2.3M (source: Derived: trailing 12 months at year end)n/a−$1.1M−$2.6M
EBIT−$8.8M (source: Derived: trailing 12 months at year end)n/a−$1.2M−$3.1M
Interest expense$12.5K (source: Derived: trailing 12 months at year end)n/a$13.4K$13.3K
Pretax income−$8.8M (source: Derived: trailing 12 months at year end)n/a−$1.2M−$3.1M
Tax$0 (source: Derived: trailing 12 months at year end)n/a$0$0
NPAT−$8.8M (source: ASX (Markit))−$943.2K (source: ASX (Markit))−$1.2M−$3.1M
Net interest income−$12.5K (source: Derived: trailing 12 months at year end)n/a−$9.0K−$13.3K
EPS basic−$0.96 (source: Derived: trailing 12 months at year end)−$0.002 (source: Derived: trailing 12 months at year end)−$0.004−$0.018
EPS diluted−$0.96 (source: Derived: trailing 12 months at year end)n/a−$0.004−$0.018
Sharesn/an/a409.6M227.4M
  • ASX (Markit)
  • Derived: trailing 12 months at year end